In­di­ana man­u­fac­tur­er to con­struct fa­cil­i­ty for ra­di­oli­gand pro­duc­tion

As com­pa­nies both large and small are con­tin­u­ing to place bets on ra­di­oli­gand ther­a­pies, the man­u­fac­tur­ing in­dus­try is ex­pand­ing to ac­com­mo­date the ris­ing in­ter­est.

In­di­ana-based Spec­tron­Rx is plan­ning to con­struct a new fa­cil­i­ty for pro­duc­ing ac­tini­um-225, which has yet to win FDA ap­proval. Spec­tron­Rx has se­cured more than 10 acres in Bunker Hill, IN, a town halfway be­tween In­di­anapo­lis and South Bend. The square footage of the fa­cil­i­ty has not been fi­nal­ized, ac­cord­ing to the com­pa­ny, but it will aim to pro­duce Ac-225 for use in clin­i­cal tri­als and com­mer­cial sup­ply of can­cer-fight­ing ther­a­pies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER